Imagen de Portada

The Potential Role of Baseline FT3/FT4 Ratio as a Prognostic Biomarker for Patients With Ischemic Non‐Obstructive Coronary Artery Disease

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Feipeng Wu, Xiandong Zheng, Liju Hong, Qiyan Wu, Rui Yang, Xiaodong Xie, Weijia Ren, Zijian Cai, Yuanyuan Xiao, Youjun Zhou
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Clinical Cardiology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

“A Biomarker‐Based Scoring System to Assess the Presence of Obstructive Coronary Artery Disease in Patients With Myocardial Infarction”
por: María Jesús Espinosa Pascual, et al.
Publicado: (2025)

Prognostic Impact of Implementation of Heart Team Approach on Cardiovascular Outcomes in Patients With Complex Coronary Artery Disease
por: Po‐Hsueh Su, et al.
Publicado: (2025)

Sex‐Specific Associations With Abnormal Myocardial Flow Reserve in Non‐Obstructive Coronary Artery Disease: Insights From a Real‐World Cadmium‐Zinc‐Telluride SPECT Study
por: Ya‐Jie Wang, et al.
Publicado: (2026)

Circulating Levels of Calprotectin as a Biomarker in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis
por: Tara Reshadmanesh, et al.
Publicado: (2024)

Prognostic Value of Platelet to Lymphocyte Ratio for Myocardial Infarction: A Systematic Review and Meta‐Analysis
por: Hengxu Yu, et al.
Publicado: (2025)

Changes of Serum CTRP12 in Patients With Coronary Artery Disease After the Treatment of Percutaneous Coronary Intervention and Its Relationship With In‐Stent Restenosis
por: Botao Zhao, et al.
Publicado: (2026)

Association Between Handgrip Strength and Mortality of Patients With Coronary Artery Disease: A Meta‐Analysis
por: Meiling Xiao, et al.
Publicado: (2024)

Management of Antithrombotic Therapy in Patients With Coexisting Atrial Fibrillation and Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention Within the Last Year
por: Sebastian König, et al.
Publicado: (2025)

Corrigendum to “Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease”
Publicado: (2025)

Critique on “Epicardial Fat Thickness as a Marker of Coronary Artery Disease in Diabetics: A Single Center Study”
por: Vishan Das, et al.
Publicado: (2026)

Association Between State‐Wide Cardiac Quality Improvement Program and Costs Following Intervention for Coronary Artery Disease
por: Edwin S. Wong, et al.
Publicado: (2024)

Is There a Need for Sex‐Tailored Lipoprotein(a) Cut‐Off Values for Coronary Artery Disease Risk Stratification?
por: Ece Yurtseven, et al.
Publicado: (2024)

Comment on “Epicardial Fat Thickness as a Marker of Coronary Artery Disease in Diabetics: A Single Center Study”
por: Mashal Naveed, et al.
Publicado: (2026)

The Plaque Analysis Classifies the Coronary Artery Disease‐Reporting and Data System (CAD‐RADS) Stenosis and Plaque Burden Categories: Association of the Plaque Features, Fat Attenuation Index, Coronary Computed Tomography Fractional Flow Reserve, and the Combination of Stenosis and Calcification
por: Wenxi Chen, et al.
Publicado: (2024)

Quadricuspid Aortic Valve With Severe Aortic Regurgitation and Coronary Artery Disease: A Rare Association
por: Asher George Joseph, et al.
Publicado: (2026)

The Effect of Different Statin‐Based Lipid‐Lowering Strategies on C‐Reactive Protein Levels in Patients With Stable Coronary Artery Disease
por: Zhimin Xue, et al.
Publicado: (2024)

Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease
por: Mushood Ahmed, et al.
Publicado: (2024)

Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm
por: Shozo Sueda, et al.
Publicado: (2024)

Underestimation of Stent Efficacy: Untreated Artery Events Distort Coronary Intervention Outcomes
por: Mauricio Rigodanzo Mocha, et al.
Publicado: (2025)

Anomalous Right Coronary Artery: Culprit or Innocent Bystander?
por: Cooper B. Kersey, et al.
Publicado: (2025)

Immediate Effect of Drug‐Eluting Balloon Angioplasty Combined With Cutting Balloon Predilatation for the Treatment of Coronary Artery Disease
por: Hangzhou Luo, et al.
Publicado: (2025)

Triple‐Vessel Spontaneous Coronary Artery Dissection Managed Conservatively
por: Garen S. Kroshian, et al.
Publicado: (2024)

Utility of SuperCross Microcatheter for Complex Coronary Artery Intervention
por: Long-Hao Yu, et al.
Publicado: (2025)

Rare Manifestation of COVID-19 Resulting in Coronary Artery Vasculitis
por: Ahmed Hassaan Qavi, et al.
Publicado: (2024)

Mapping the Evolution of Drug‐Coated Balloon Research in Coronary Artery Disease: A 2006–2023 Bibliometric and Visual Analysis
por: Jiayang Dong, et al.
Publicado: (2025)

Coronary Steal Syndrome due to a Side Branch of the LIMA in Patients Undergoing Coronary Artery Bypass Grafting
por: Adrien Jossart, et al.
Publicado: (2025)

Incremental Value of Non‐Gated Chest CT Coronary Artery Calcium Score in Predicting Major Adverse Cardiovascular Events by GRACE Score After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome
por: Zhaoyuan Xing, et al.
Publicado: (2025)

Identification of Plasma Exosomes hsa_circ_0001360 and hsa_circ_0000038 as Key Biomarkers of Coronary Heart Disease
por: Wan Zhang, et al.
Publicado: (2024)

Combined Minimally Invasive Surgical and Percutaneous Approaches for a Patient on Hemodialysis With Severe Aortic Stenosis and Complex Coronary Artery Disease
por: Teruaki Wada, et al.
Publicado: (2025)

Comparing the Performances of Support Vector Machines and Artificial Neural Networks for Predicting Coronary Artery Diseases: A Cross‐Sectional Study
por: Sahar Shariatnia, et al.
Publicado: (2026)

Prevalence and Determinants of Coronary Artery Calcification in Adults With Metabolic Syndrome: A Systematic Review and Meta‐Analysis
por: Aftab Ullah, et al.
Publicado: (2025)

Incorporating Inflammation Biomarker‐Driven Multivariate Predictive Model for Coronary Microcirculatory Dysfunction in Acute Myocardial Infarction Following Emergency Percutaneous Coronary Intervention
por: Zhuoya Yao, et al.
Publicado: (2024)

C ‐Reactive Protein–Triglyceride–Glucose Index and Coronary Artery Calcium Progression: A Prospective Cohort Analysis
por: Qing‐Yun Hao, et al.
Publicado: (2026)

Exome Sequencing Identified Susceptible Genes for High Residual Risks in Early‐Onset Coronary Atherosclerotic Disease
por: Runda Wu, et al.
Publicado: (2024)

Long‐Term Effectiveness of a Stent‐Less Strategy With Drug Coated Balloon in Coronary Artery Disease: 3‐Year Follow‐Up of a Prospective All‐Comers Observational Study
por: Ludovic Meunier, et al.
Publicado: (2025)

Delayed Coronary Artery Perforation of a Nontarget Distal Small Side Branch With Subsequent Cardiac Tamponade After Percutaneous Coronary Intervention
por: Masaki Fujiwara, et al.
Publicado: (2025)

Naples Prognostic Score and Clinical Outcomes After PCI for Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis
por: Yasin Özen, et al.
Publicado: (2025)

Reconsidering the Prognostic Role of the HALP Score in Rheumatic Mitral Stenosis
por: Muhammad Talha, et al.
Publicado: (2026)

Establishing a Predictive Model for the Occurrence of CI‐AKI After PCI in Patients With Coronary Heart Disease Based on Serum‐Derived Biomarkers
por: Qin-yu Sun, et al.
Publicado: (2025)

Long‐Term Clinical Outcomes of CABG vs. PCI With DES for Multivessel and Left‐Main Coronary Artery Disease: A Systematic Review and Meta‐Analysis
por: Muhammad M. Saleem, et al.
Publicado: (2026)